Cargando…

Leishmaniasis and Chagas disease: Is there hope in nanotechnology to fight neglected tropical diseases?

Nanotechnology is revolutionizing many sectors of science, from food preservation to healthcare to energy applications. Since 1995, when the first nanomedicines started being commercialized, drug developers have relied on nanotechnology to improve the pharmacokinetic properties of bioactive molecule...

Descripción completa

Detalles Bibliográficos
Autores principales:	Scariot, Debora B., Staneviciute, Austeja, Zhu, Jennifer, Li, Xiaomo, Scott, Evan A., Engman, David M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cellular and Infection Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523166/ https://www.ncbi.nlm.nih.gov/pubmed/36189341 http://dx.doi.org/10.3389/fcimb.2022.1000972

Ejemplares similares

Precision Health for Chagas Disease: Integrating Parasite and Host Factors to Predict Outcome of Infection and Response to Therapy
por: Martinez, Santiago J., et al.
Publicado: (2020)

Revisiting Drug Development Against the Neglected Tropical Disease, Amebiasis
por: Shrivastav, Manish T., et al.
Publicado: (2021)

Editorial: New strategies and technologies enabling point of care diagnosis of neglected or tropical diseases
por: Costa, Alexandre Dias Tavares, et al.
Publicado: (2022)

An Overview on the Therapeutics of Neglected Infectious Diseases—Leishmaniasis and Chagas Diseases
por: J, Brindha, et al.
Publicado: (2021)

Chagas Disease and the London Declaration on Neglected Tropical Diseases
por: Tarleton, Rick L., et al.
Publicado: (2014)

Editorial: World Chagas disease day 2022
por: Palmisano, Giuseppe, et al.
Publicado: (2023)

Discovery and Genetic Validation of Chemotherapeutic Targets for Chagas' Disease
por: Osorio-Méndez, Juan Felipe, et al.
Publicado: (2019)

Editorial: Chagas disease novel drug targets and treatments
por: Duschak, Vilma G., et al.
Publicado: (2023)

Gut Dysbiosis in Chagas Disease. A Possible Link to the Pathogenesis
por: de Souza-Basqueira, Marcela, et al.
Publicado: (2020)

Role of the Complement System in the Modulation of T-Cell Responses in Chronic Chagas Disease
por: Caputo, María Belén, et al.
Publicado: (2022)

Therapeutic Interventions for Countering Leishmaniasis and Chagas’s Disease: From Traditional Sources to Nanotechnological Systems
por: Souto, Eliana B., et al.
Publicado: (2019)

Editorial: Tropical fungal diseases
por: Taborda, Carlos P., et al.
Publicado: (2022)

Archaea Symbiont of T. cruzi Infection May Explain Heart Failure in Chagas Disease
por: Higuchi, Maria de Lourdes, et al.
Publicado: (2018)

Sirtuin Control of Mitochondrial Dysfunction, Oxidative Stress, and Inflammation in Chagas Disease Models
por: Wan, Xianxiu, et al.
Publicado: (2021)

Psychosocial burden of neglected tropical diseases in eastern Colombia: an explorative qualitative study in persons affected by leprosy, cutaneous leishmaniasis and Chagas disease
por: van Wijk, Robin, et al.
Publicado: (2021)

Yemen: Fighting Neglected Tropical Diseases against All Odds
por: Baring, Elisa, et al.
Publicado: (2014)

Trypanosoma cruzi trans-Sialidase as a Potential Vaccine Target Against Chagas Disease
por: da Costa, Kelli Monteiro, et al.
Publicado: (2021)

Trypanosoma cruzi Induces Regulatory B Cell Alterations in Patients With Chronic Chagas Disease
por: Girard, Magalí C., et al.
Publicado: (2021)

The Search for Biomarkers and Treatments in Chagas Disease: Insights From TGF-Beta Studies and Immunogenetics
por: Ferreira, Roberto Rodrigues, et al.
Publicado: (2022)

Does Autoimmunity Play a Role in the Immunopathogenesis of Vasculitis Associated With Chronic Chagas Disease?
por: Garcia-Bustos, Victor, et al.
Publicado: (2021)

Immunomodulation for the Treatment of Chronic Chagas Disease Cardiomyopathy: A New Approach to an Old Enemy
por: Santos, Emanuelle de Souza, et al.
Publicado: (2021)

Circulating T Follicular Helper Cell Abnormalities Associated to Different Clinical Forms of Chronic Chagas Disease
por: Quebrada Palacio, Luz P., et al.
Publicado: (2020)

Trypanosoma Species in Small Nonflying Mammals in an Area With a Single Previous Chagas Disease Case
por: Dario, Maria Augusta, et al.
Publicado: (2022)

Hallmarks of the relationship between host and Trypanosoma cruzi sulfated glycoconjugates along the course of Chagas disease
por: Soprano, Luciana L., et al.
Publicado: (2023)

Psychosocial burden of neglected tropical diseases in eastern Colombia: an explorative qualitative study in persons affected by leprosy, cutaneous leishmaniasis and Chagas disease – ERRATUM
por: van Wijk, Robin, et al.
Publicado: (2021)

Differential Expression of Immune Response Genes in Asymptomatic Chronic Chagas Disease Patients Versus Healthy Subjects
por: Gómez, Inmaculada, et al.
Publicado: (2021)

Vaccine-linked chemotherapy improves cardiac structure and function in a mouse model of chronic Chagas disease
por: Jones, Kathryn M., et al.
Publicado: (2023)

Editorial: Discovery and Development of Drugs for Neglected Diseases: Chagas Disease, Human African Trypanosomiasis, and Leishmaniasis
por: Rivera, Gildardo, et al.
Publicado: (2021)

Neglected Agent Eminent Disease: Linking Human Helminthic Infection, Inflammation, and Malignancy
por: Arora, Naina, et al.
Publicado: (2019)

Characterization and Follow-Up of Trypanosoma cruzi Natural Populations Refractory to Etiological Chemotherapy in Oral Chagas Disease Patients
por: Muñoz-Calderón, Arturo, et al.
Publicado: (2021)

Fenofibrate Increases the Population of Non-Classical Monocytes in Asymptomatic Chagas Disease Patients and Modulates Inflammatory Cytokines in PBMC
por: Pieralisi, Azul V., et al.
Publicado: (2022)

In Chagas disease, transforming growth factor beta neutralization reduces Trypanosoma cruzi infection and improves cardiac performance
por: Ferreira, Roberto Rodrigues, et al.
Publicado: (2022)

Biomarkers of Cutaneous Leishmaniasis
por: Bahrami, Fariborz, et al.
Publicado: (2018)

Editorial: Biomarkers in Leishmaniasis
por: Carrillo, Eugenia, et al.
Publicado: (2019)

Humoral response in Leishmaniasis
por: Conde, Luciana, et al.
Publicado: (2022)

The repositioned drugs disulfiram/diethyldithiocarbamate combined to benznidazole: Searching for Chagas disease selective therapy, preventing toxicity and drug resistance
por: Almeida-Silva, Juliana, et al.
Publicado: (2022)

Editorial: One Health Approach in Zoonosis: strategies to control, diagnose and treat neglected diseases
por: Quaresma, Patricia Flavia, et al.
Publicado: (2023)

Mechanisms of Immunopathogenesis in Cutaneous Leishmaniasis And Post Kala-azar Dermal Leishmaniasis (PKDL)
por: Volpedo, Greta, et al.
Publicado: (2021)

Repurposing Carvedilol as a Novel Inhibitor of the Trypanosoma cruzi Autophagy Flux That Affects Parasite Replication and Survival
por: Rivero, Cynthia Vanesa, et al.
Publicado: (2021)

Neuronal Parasitism, Early Myenteric Neurons Depopulation and Continuous Axonal Networking Damage as Underlying Mechanisms of the Experimental Intestinal Chagas' Disease
por: Ricci, Mayra Fernanda, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_nm2nheoaghcpr1f759haglolk9